Mission Statement
Our mission at MicroGenDX is to improve clinical outcomes by offering clinicians and their patients the most informative and impactful microbial diagnostic tests that science can provide.
Bringing desperately needed advances in diagnostics to providers and patients
Southwest Regional PCR first offered a 2-step process combining qPCR and NGS to identify microbes in 2010 under the commercial name PathoGenius. In 2017, the laboratory was purchased by Rick Martin, head of commercialization for this testing, and rebranded as Southwest Regional PCR dba MicroGenDX. Since that new branding and leadership, the laboratory has grown in scale and reach for physicians, specialties and infection types – both nationally and internationally.
A global leader in NGS diagnostics of infection
MicroGenDX laboratory has run over 700,000 next-gen DNA sequencing tests at our state-of-the-art, CAP-accredited, CLIA-licensed molecular diagnostic facility. Our advanced instrumentation, including Illumina Miseq sequencers, provides the industry’s most informative microbial diagnostics for ENT/AFB, microbiology laboratories, orthopedics, urology, wound care, podiatry, pulmonary, ExPlants, periodontal, podiatry/nail, OB-GYN, infectious disease, and other medical specialties. Our laboratory is supported by a team of molecular biologists, biochemists, bioinformaticians, computer scientists, and physicians. MicroGenDX employs over 200 passionate employees, with a leadership model that swiftly adapts to global health concerns and new technologies. We want to help as many people as possible with microbial identification of challenging infections.
Click Below to View Our Licenses
Southwest Regional PCR Laboratory LLC dba MicroGenDX® Laboratory is a CAP-accredited, CLIA-licensed clinical diagnostic laboratory providing physicians and their patients with the most advanced molecular based microbial testing available. The laboratory utilizes molecular diagnostics and specializes in Next Generation DNA Sequencing technologies to identify pathogenic microbes within patient samples. MicroGenDX® is currently licensed to provide these services in all 50 states. Most states do not require additional licensure beyond CAP accreditation and CLIA licensing.
Click links below to see current images of our licenses, or contact us with specific questions regarding your location.
![New York State License](https://microgendx.com/wp-content/uploads/2024/01/NY-License-12.15.23-6.30.24.png")
Immediate action: our response to COVID-19
Within the first few weeks of the COVID-19 global pandemic, our team validated a real-time Reverse Transcriptase PCR (rRT-PCR) assay for the detection of the SARS-CoV-2 virus using saliva, sputum and nasal swabs. We increased laboratory capacity in response to the pandemic, allowing us to run over 5,000 samples per day. Our rapid COVID-19 PCR test is FDA EUA approved and has a 24-hour turnaround from the time of sample receipt.
Business Description
Southwest Regional PCR is a CAP accredited and CLIA licensed clinical diagnostic laboratory doing business as MicroGen Diagnostics, LLC as of April, 2017. Founded by an esteemed wound care doctor Randall Wolcott in 2008, and currently owned and operated by Rick Martin, a former Pfizer executive, who personally witnessed the positive clinical impact of qPCR+NGS, MicrogenDX is bringing state-of-the-art microbial DNA sequencing diagnostics to more patients every day – processing more than 100,000 samples each year.
